Summary Slide.png (102.35 kB)
Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina
figure
posted on 2021-02-12, 11:06 authored by Adis journals on behalf of, Victoria Wurcel, Emilie Scherrer, Raquel Aguiar-Ibanez, Juan Ignacio Altuna, Fernando Carabajal, Shrishti Jain, Gargi BaluniArticle full text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
